Boussard & Gavaudan Investment Management »

Ironwood Pharmaceuticals shares owned by Boussard & Gavaudan Investment Management

Quarter-by-quarter ownership of Ironwood Pharmaceuticals shares owned by Boussard & Gavaudan Investment Management from 13F filings

Historical chart of Boussard & Gavaudan Investment Management investment in Ironwood Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ironwood Pharmaceuticals held by Boussard & Gavaudan Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ironwood Pharmaceuticals by Boussard & Gavaudan Investment Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $6.5M 6.6k 985.72
2023-06-30 $6.7M 6.6k 1024.38

More positions owned by Boussard & Gavaudan Investment Management

Activision Blizzard
Horizon Therapeutics Pub L SHS
Chart Inds Note 1.000%11/1
Vmware Cl A Com
Seagen
Cnx Res Corp Note 2.250% 5/0
Booking Holdings Note 0.750% 5/0
Altair Engr Note 0.250% 6/0
Permian Resources Corp Note 3.250% 4/0
On Semiconductor Corp Note 5/0
Westrock (WRK)
Bgc Group Cl A (BGC)
Ambac Finl Group Com New (AMBC)
Cinemark Hldgs Note 4.500% 8/1
Dynavax Technologies Corp Note 2.500% 5/1

View all positions for Boussard & Gavaudan Investment Management

Top funds holding Ironwood Pharmaceuticals

Wolverine Asset Management
Wellesley Investment Advisors
Balyasny Asset Management
Braidwell
Capstone Investment Advisors
Readystate Asset Management
Calamos Advisors
CSS
Jane Street
Jpmorgan Chase & Co
Shenkman Capital Management
Citigroup
Bank of New York Mellon
D.A. Davidson & Co.
First Hawaiian Bank

View all funds holding Ironwood Pharmaceuticals